TNFα induces HIF-1α expression through activation of IKKβ

Biochemical and Biophysical Research Communications

Volumn 389, Issue 4, 2009, Pages 640-644

  Kuo, Hsu Ping ^a,b   Lee, Dung Fang ^a,b   Xia, Weiya ^a   Wei, Yongkun ^a   Hung, Mien Chie ^a,b,c,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Hypoxia inducible factor 1 ; I B kinase ; Tumor necrosis factor ; Vascular endothelial growth factor

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B KINASE BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; I-KAPPA B KINASE; MICE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349738078     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.042     Document Type: Article

References (25)

1. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
2. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
3. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. 3 (2003) 721-732
4. Huang L.E., and Bunn H.F. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278 (2003) 19575-19578
5. Hellwig-Burgel T., Rutkowski K., Metzen E., Fandrey J., and Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94 (1999) 1561-1567
6. Thornton R.D., Lane P., Borghaei R.C., Pease E.A., Caro J., and Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350 Pt. 1 (2000) 307-312
7. Sodhi A., Montaner S., Miyazaki H., and Gutkind J.S. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem. Biophys. Res. Commun. 287 (2001) 292-300
8. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., and Semenza G.L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60 (2000) 1541-1545
9. Hur E., Chang K.Y., Lee E., Lee S.K., and Park H. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol. Pharmacol. 59 (2001) 1216-1224
10. Sang N., Stiehl D.P., Bohensky J., Leshchinsky I., Srinivas V., and Caro J. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem. 278 (2003) 14013-14019
11. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
12. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., and Hung M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
13. Yang J.Y., Zong C.S., Xia W., Yamaguchi H., Ding Q., Xie X., Lang J.Y., Lai C.C., Chang C.J., Huang W.C., Huang H., Kuo H.P., Lee D.F., Li L.Y., Lien H.C., Cheng X., Chang K.J., Hsiao C.D., Tsai F.J., Tsai C.H., Sahin A.A., Muller W.J., Mills G.B., Yu D., Hortobagyi G.N., and Hung M.C. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat. Cell Biol. 10 (2008) 138-148
14. Lee D.F., Kuo H.P., Chen C.T., Hsu J.M., Chou C.K., Wei Y., Sun H.L., Li L.Y., Ping B., Huang W.C., He X., Hung J.Y., Lai C.C., Ding Q., Su J.L., Yang J.Y., Sahin A.A., Hortobagyi G.N., Tsai F.J., Tsai C.H., and Hung M.C. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130 (2007) 440-455
15. Inoki K., Li Y., Zhu T., Wu J., and Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4 (2002) 648-657
16. Ma L., Chen Z., Erdjument-Bromage H., Tempst P., and Pandolfi P.P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121 (2005) 179-193
17. Lee D.F., and Hung M.C. Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin. Cancer Res. 14 (2008) 5656-5662
18. Kuo H.P., Lee D.F., Xia W., Lai C.C., Li L.Y., and Hung M.C. Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation. Biochem Biophys. Res. Commun. 389 (2009) 156-161
19. Lee D.F., and Hung M.C. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 6 (2007) 3011-3014
20. Yen C.J., Izzo J.G., Lee D.F., Guha S., Wei Y., Wu T.T., Chen C.T., Kuo H.P., Hsu J.M., Sun H.L., Chou C.K., Buttar N.S., Wang K.K., Huang P., Ajani J., and Hung M.C. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res. 68 (2008) 2632-2640
21. Li Y.M., Zhou B.P., Deng J., Pan Y., Hay N., and Hung M.C. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells. Cancer Res. 65 (2005) 3257-3263
22. Zou Y., Peng H., Zhou B., Wen Y., Wang S.C., Tsai E.M., and Hung M.C. Systemic tumor suppression by the proapoptotic gene bik. Cancer Res. 62 (2002) 8-12
23. Camp R.L., Rimm E.B., and Rimm D.L. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86 (1999) 2259-2265
24. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270 (1995) 13333-13340
25. Lo H.W., Xia W., Wei Y., Ali-Seyed M., Huang S.F., and Hung M.C. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 65 (2005) 338-348